LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
September 09, 2008 (PRLEAP.COM) Health NewsDenver, CO - LegalView recently alerted patients taking proton pump inhibitor (PPI) drugs of the potential for serious bone fracture risks associated with taking the medication. A study published in a recent issue of the Canadian Medical Association Journal found that patients using PPIs for continued use (5 to 7 years or more) are at an increased risk of developing hip, spinal or wrist fractures. According to the study, patients at the most risk include those of 50 years of age or older.
Individuals who are currently prescribed to any of the proton pump inhibitors such as pantoprazole, rabeprazole, esomeprazole, lansoprazole and omeprazole are encouraged to contact an experienced pharmaceutical lawyer to better understand how to develop a potential PPI lawsuit.
PPIs are used to inhibit gastric secretion entering the stomach. A pump within the stomach that funnels gastric acids is stopped when taking PPIs. These drugs treat an array of conditions including peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), prevention of stress gastritis, gastrinomas, dyspepsia, etc. However, the drugs may also stop the absorption of calcium while stopping the secretion of gastric acids thus causing bone fractures. The PPI side effects also includes headache, nausea, diarrhea, dizziness, abdominal pain, dizziness and fatigue. To learn more about how proton pump inhibitors work and who is at risk for the drug's side effects, visit http://proton-pump-inhibitors-ppi.legalview.com/.
LegalView also offers details on other legal topics and offers readers a library of information portals relating to several controversial pharmaceutical drugs/products such as Avandia, Ketek and the Zimmer Durom cups.
Avandia is a type 2 diabetes drug that has continued to find its way into news headlines over the drug's side effects. Several studies have concluded that the Avandia risks may cause serious complications for patients. The drug has been linked to early on-set osteoporosis, increased risk of bone fracture, heart failure and unstable angina.
Since 2004, Ketek has been prescribed to patients suffering from upper respiratory infections. The FDA has been investigating accounts of liver disease and liver failure developing among Ketek patients. Additionally, patients of the antibiotic showing any signs of the Ketek side effects , which include yellowing or jaundice of the skin, are advised to discontinue use of the drug and consult a physician.
The Durom cup is an artificial hip socket component used in hip replacement surgeries. However, physicians recently began to complain that the hip socket was failing in many patients. Since reports of the Zimmer Durom cup failure have began the company has halted production of additional Durom cups, however, no recall has been issued.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.